Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,679 | -26,354 | -14,573 | -34,598 | -27,421 |
| Depreciation Amortization | 318 | 228 | 121 | 641 | 504 |
| Accounts payable and accrued liabilities | -181 | -440 | 58 | 875 | 1,381 |
| Other Working Capital | -3,448 | -2,874 | -3,224 | -7,113 | -4,512 |
| Other Operating Activity | 10,824 | 7,814 | 6,185 | 2,772 | 2,326 |
| Operating Cash Flow | $-34,166 | $-21,626 | $-11,433 | $-37,423 | $-27,722 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -23 | -23 | N/A | N/A |
| Purchase Of Investment | -37,947 | -32,934 | -12,303 | -26,894 | -22,602 |
| Sale Of Investment | 38,201 | 25,320 | 16,180 | 59,110 | 55,268 |
| Investing Cash Flow | $206 | $-7,637 | $3,854 | $32,216 | $32,666 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,583 | 45,476 | 45,073 | 12,570 | 6,819 |
| Other Financing Activity | -6,937 | -4,573 | -2,261 | -7,182 | -4,971 |
| Financing Cash Flow | $39,646 | $40,903 | $42,812 | $5,388 | $1,848 |
| Beginning Cash Position | 15,121 | 15,121 | 15,121 | 14,940 | 14,940 |
| End Cash Position | 20,807 | 26,761 | 50,354 | 15,121 | 21,732 |
| Net Cash Flow | $5,686 | $11,640 | $35,233 | $181 | $6,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,166 | -21,626 | -11,433 | -37,423 | -27,722 |
| Capital Expenditure | -48 | -23 | -23 | N/A | 0 |
| Free Cash Flow | -34,214 | -21,649 | -11,456 | -37,423 | -27,722 |